CN1048409C - Capsule for protecting liver and eliminating tumor - Google Patents
Capsule for protecting liver and eliminating tumor Download PDFInfo
- Publication number
- CN1048409C CN1048409C CN94112640A CN94112640A CN1048409C CN 1048409 C CN1048409 C CN 1048409C CN 94112640 A CN94112640 A CN 94112640A CN 94112640 A CN94112640 A CN 94112640A CN 1048409 C CN1048409 C CN 1048409C
- Authority
- CN
- China
- Prior art keywords
- herba
- processed
- capsule
- radix
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention discloses a capsule for mainly treating liver cancer, protecting the liver and eliminating tumors, which has better therapeutic effect on breast cancer and gastric cancer simultaneously. The capsule is prepared from about 20 Chinese herbal medicines and has the characteristics of short treating course and no toxic or side effect.
Description
The invention belongs to compound Chinese medicinal preparation, be used for the treatment of tumor disease, be particularly useful for treating hepatocarcinoma, simultaneously gastric cancer and breast carcinoma are also had better curative effect.
Hepatocarcinoma is " king in the cancer ", is one of modal malignant tumor in the world, and mortality rate is higher, and the medicine to the treatment ideal of this disease is very few at present.Hepatocarcinoma is that tangible buildup is in liver, carcinoma is the thing of evil poison, so the method for employing " treating the poisonous disease with poisonous drugs " is arranged, in the prescription of controlling the cancer medicine, the speckle insect destructive of the roots of seedlings, Scolopendra, Bufo siccus that useful toxicity is bigger, this medicine can play certain lethal effect to cancerous cell, but simultaneously human normal tissue cell is is also killed and wounded, take for a long time, be unfavorable for physical and mental health, and have the low deficiency of curative effect.
The present invention seeks to provides a kind of heat-clearing and toxic substances removing at above-mentioned deficiency, the liver eliminating stagnation that disappears, curative effect height, the treatment hepatocarcinoma new drug building lotus capsule of the pure Chinese medicinal preparation that employing avirulence Chinese medicine is formed.
The object of the present invention is achieved like this: hepatocarcinoma mostly is the disease of simulataneous insufficiency and excessive, and void is more common in the positive QI-insufficiency of whole body, sees with deficiency of both QI and YIN more; Be more common in the part in fact, with stagnation of QI-blood, excessive noxious heat is main, positive exogenous pathogen is contained, and depression and stagnation of QI is a basic pathogenesis, and satisfying with " setting upright tonification; blood circulation promoting and blood stasis dispelling, broken disease eliminating stagnation, regulating QI to relieve pain " is aim, determine that the principles of formulating prescriptions are " heat-clearing and toxic substances removing, blood stasis-eliminating and stagnation-dissipating ", Fa Ming building lotus capsule is made by following proportion raw material by weight thus: Herba Hedyotidis Diffusae 70-100 part, Rhizoma Paridis 70-100 part, Herba Lobeliae Chinensis 70-100 part, Herba Solani Nigri 70-100 part, Herba Scutellariae Barbatae 70-100 part, Herba Solani Lyrati 70-100 part, Radix Semiaquilegiae 14-20 part, Fructus Polygoni Orientalis 14-20 part, Rhizoma Curcumae 14-20 part, Pulvis Cornus Bubali Concentratus 7-10 part, Olibanum (processed) 4-6 part, Myrrha (processed) 4-6 part, Hirudo 14-20 part, Eupolyphaga Seu Steleophaga 7-10 part, Radix Ginseng 14-20 part, Radix Polygoni Multiflori Preparata 14-20 part, Carapax Trionycis (processed) 14-20 part, Fructus Mume (meat) 7-10 part, Endothelium Corneum Gigeriae Galli 7-10 part, Fructus Amomi 8-12 part.
This prescription is a monarch drug with Herba Hedyotidis Diffusae, Radix Semiaquilegiae, Rhizoma Paridis, Herba Lobeliae Chinensis, Herba Scutellariae Barbatae, Herba Solani Nigri, Herba Solani Lyrati, has heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, to reach the toxic swelling caking of removing due to the showing tremendous enthusiasm poison of body endogenous dampness.But the heat-clearing and toxic substances removing medicine not only early prevention and treatment in elder generation, and to mid-term the patient usefulness of Qinghua fire-toxin is arranged, to reach the control carcinoma, prevent that other complication from taking place; With Fructus Polygoni Orientalis, Rhizoma Curcumae, Cornu Bubali, Olibanum, Myrrha, Hirudo, Eupolyphaga Seu Steleophaga is ministerial drug, has logical lively atmosphere blood, row wet dissipation heat, reducing swelling and alleviating pain is searched and is picked old amassing, and changes the eliminating mass abdominal mass and gathers, seven medicines must be joined, and specially change the dead blood of pertinacious phlegm, dredging the meridian, hard masses softening and resolving: with Radix Ginseng, Radix Polygoni Multiflori, Carapax Trionycis, Fructus Mume, Endothelium Corneum Gigeriae Galli, Fructus Amomi is adjuvant, but invigorating primordial QI, beneficial the five internal organs, the yin nourishing of enriching blood, the appetizing of being amusing, six medicine compatibilities, qi and blood tonifying, strengthening the body resistance, the evil poison diffusion of retardance.This medicine monarch, prescription is careful, plays the eliminate indigestion that uncharms altogether, the effect of liver-protecting and cancer-resisting.
This medicament preparation is as follows: Olibanum, Myrrha, Radix Polygoni Multiflori, Carapax Trionycis adopt concocted specification to carry out; Adopt water to extract its active ingredient to Herba Hedyotidis Diffusae, Rhizoma Paridis, Herba Lobeliae Chinensis, Herba Solani Nigri, Herba Scutellariae Barbatae, Herba Solani Lyrati, Radix Semiaquilegiae, specific practice is to get each herbal medicine of afore mentioned rules umber, put in the extraction vessel respectively, adding water temperature soaked 2-3 hour, each extracts three times, merge three times extracting solution, be condensed into extractum; Other each herbal medicines to not adopting water to carry in the prescription are ground into fine powder, puddle into chunky shape with extractum then, carry out drying, porphyrize, sieve, be mixed, check encapsulated or make electuary.
This medicine function: heat-clearing and toxic substances removing, blood stasis-eliminating and stagnation-dissipating.
This medicine cures mainly: hepatocarcinoma I, II phase, traditional Chinese medical science typing: damp-heat type, blood stasis type.Also effective in cure to gastric cancer, breast carcinoma simultaneously.
Usage and consumption: every day 3 times, each 6 (every of 0.25g/), and 28 days is a course of treatment, can obviously take effect a general course of treatment.
This medicine advantage is: 1, have no side effect.Show to the white mice acute toxinology experiment with to the rat long term toxicity test that through the Tianjin Institute of Medicine Science large and small white mouse does not all have poisoning and other abnormal phenomena, so clinical use should be safer.2, killing hepatoma cytosis is preferably arranged, cancer suppressing ratio can reach 94.6%.Through Academy of Military Medicine, PLA's effect experiment, by showing to the observation of curative effect of BALB/C nude mice transplantability people hepatocarcinoma and to the experimental result of the human liver cancer cell of In vitro culture, cancer suppressing ratio reaches 94.6%, observe liver cancer tissue, its major injury, the cell enlargement active degree lowers, and can see extensively, the downright bad hemorrhage district of lamellar, does not see that cancerous cell organizes interior infiltrative growth towards periphery.Cell in vitro experiment is shown this medicine has and kills and wounds the cancerous cell effect preferably, with the curative effect basically identical to the nude mice transplanted hepatoma.3, this medicine can significantly suppress hepatocarcinoma, breast carcinoma and vitro growth of gastric cancer cell.Experiment shows that this medicine can suppress the growth and the proliferation function of hepatocarcinoma, gastric cancer, breast cancer cell to the In vitro culture cancerous cell through Royal Bank Venture Capital Co., Ltd.
Embodiment:
Component | Content (kg) | |
Embodiment 1 | Embodiment 2 | |
Herba Hedyotidis Diffusae | 100 | 70 |
Rhizoma Paridis | 100 | 70 |
Herba Lobeliae Chinensis | 100 | 70 |
Herba Solani Nigri | 100 | 70 |
Herba Scutellariae Barbatae | 100 | 70 |
Herba Solani Lyrati | 100 | 70 |
Radix Semiaquilegiae | 20 | 16 |
Fructus Polygoni Orientalis | 20 | 16 |
Rhizoma Curcumae | 20 | 16 |
Pulvis Cornus Bubali Concentratus | 10 | 8 |
Olibanum (system) | 6 | 5 |
Myrrha (processed) | 6 | 5 |
Hirudo | 20 | 16 |
Eupolyphaga Seu Steleophaga | 10 | 8 |
Radix Ginseng | 20 | 16 |
Radix Polygoni Multiflori (system) | 20 | 16 |
Carapax Trionycis (system) | 20 | 16 |
Fructus Mume (meat) | 10 | 8 |
Endothelium Corneum Gigeriae Galli | 10 | 8 |
Fructus Amomi | 12 | 10 |
Claims (1)
1, a kind of hepatocarcinoma that cures mainly is simultaneously to breast carcinoma, gastric cancer also has the building lotus capsule of therapeutic effect, it is characterized in that it is made by following proportion raw material by weight: Herba Hedyotidis Diffusae 70-100 part, Rhizoma Paridis 70-100 part, Herba Lobeliae Chinensis 70-100 part, Herba Solani Nigri 70-100 part, Herba Scutellariae Barbatae 70-100 part, Herba Solani Lyrati 70-100 part, Radix Semiaquilegiae 14-20 part, Fructus Polygoni Orientalis 14-20 part, Rhizoma Curcumae 14-20 part, Pulvis Cornus Bubali Concentratus 7-10 part, Olibanum (processed) 4-6 part, Myrrha (processed) 4-6 part, Hirudo 14-20 part, Eupolyphaga Seu Steleophaga 7-10 part, Radix Ginseng 14-20 part, Radix Polygoni Multiflori Preparata 14-20 part, Carapax Trionycis (processed) 14-20 part, Fructus Mume 7-10 part, Endothelium Corneum Gigeriae Galli 7-10 part, Fructus Amomi 8-12 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94112640A CN1048409C (en) | 1994-11-22 | 1994-11-22 | Capsule for protecting liver and eliminating tumor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN94112640A CN1048409C (en) | 1994-11-22 | 1994-11-22 | Capsule for protecting liver and eliminating tumor |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1123669A CN1123669A (en) | 1996-06-05 |
CN1048409C true CN1048409C (en) | 2000-01-19 |
Family
ID=5036312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94112640A Expired - Fee Related CN1048409C (en) | 1994-11-22 | 1994-11-22 | Capsule for protecting liver and eliminating tumor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1048409C (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1084200C (en) * | 1999-06-02 | 2002-05-08 | 刘寿臣 | Anticancer pill and its preparing process |
CN101138612B (en) * | 2006-10-13 | 2011-12-07 | 桂林商源植物制品有限公司 | Antineoplastic preparations and method of preparing the same |
CN101897869B (en) * | 2010-07-09 | 2011-08-31 | 李希民 | Medicament for treating tumor |
CN102805840B (en) * | 2012-08-21 | 2014-06-11 | 亳州康复肿瘤药物研究所 | Complex anti-tumor traditional Chinese medicine preparation |
CN103520652B (en) * | 2013-10-25 | 2015-04-22 | 陈静静 | Traditional Chinese medicine composition for treating liver cancer |
CN103736009A (en) * | 2013-12-27 | 2014-04-23 | 刘玉含 | Liomyoma nursing medicament and preparation method thereof |
CN104083712A (en) * | 2014-06-19 | 2014-10-08 | 通化万通药业股份有限公司 | Medicine for treating liver cancer and preparation method thereof |
CN104645254A (en) * | 2015-03-23 | 2015-05-27 | 陈泽林 | Antitumor drug and preparation method thereof |
CN105148139A (en) * | 2015-10-21 | 2015-12-16 | 罗盈 | Traditional Chinese medicine for treating cervical cancer |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1075886A (en) * | 1993-01-20 | 1993-09-08 | 潘敏求 | A kind of medicine and manufacture method thereof for the treatment of hepatocarcinoma |
-
1994
- 1994-11-22 CN CN94112640A patent/CN1048409C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1075886A (en) * | 1993-01-20 | 1993-09-08 | 潘敏求 | A kind of medicine and manufacture method thereof for the treatment of hepatocarcinoma |
Non-Patent Citations (1)
Title |
---|
《肿瘤》1989年第9卷第5期 1989.5.31 陈林才,以中药为主治疗肝癌41例 * |
Also Published As
Publication number | Publication date |
---|---|
CN1123669A (en) | 1996-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048894B (en) | Traditional Chinese medicine composition for treating burn and preparation method thereof | |
CN102091203B (en) | External traditional Chinese medicine preparation for treating refractory wound and preparation method thereof | |
CN101732683A (en) | Chinese medicinal preparation for treating facial chloasma and preparation method thereof | |
CN102657745A (en) | Medicinal composition with effect of removing chloasma | |
CN102861287B (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
CN1048409C (en) | Capsule for protecting liver and eliminating tumor | |
CN104127813A (en) | Traditional Chinese medicinal composition for curing qi-blood deficiency type bedsore and preparation method thereof | |
CN101926976B (en) | Pill for treating angiitis | |
CN100386106C (en) | Medicine for treating acne and its preparation | |
CN102018793B (en) | Medicine and rectum drop detoxification solution used for treating tumour and drop appliance of rectum drop detoxification solution | |
CN100411666C (en) | Broad-specturm medicine for treating snake venom poisoning | |
CN104548008A (en) | Pharmaceutical composition for preventing and/or treating allergic skin diseases and preparation method for pharmaceutical composition | |
CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
CN117462620B (en) | A Chinese medicine formula for treating lung cancer, and its preparation method and application | |
CN105687522A (en) | Pharmaceutical composition with chloasma removing function and preparation method thereof | |
CN1061867C (en) | Powder medicine for tumour | |
CN102872210B (en) | Traditional Chinese medicine for treating urticaria | |
CN101224295A (en) | Chinese traditional medicine compounds for treating digestive system tumor and preparing method thereof | |
CN1092063C (en) | Recipe of medicine for acne and plane warts | |
CN1050759C (en) | Medicinal composite for hysteromyoma and preparing method | |
CN105727069A (en) | Medicinal composition for treating chronic cholecystitis and preparation method for medicinal composition | |
CN106619852A (en) | Traditional Chinese medicine lavipeditum life cultivation and health preservation prescription with effects of warming channels and dispersing cold, and dredging grain of skin and texture of the subcutaneous flesh | |
CN1251765A (en) | Chinese medicine for treating cancers | |
CN104998019A (en) | Traditional Chinese medicine composition for promoting blood circulation for removing blood stasis and reliving bleeding and pain | |
CN1294938C (en) | Skin inflammation eliminating tincture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |